Bill Text: MI HB4155 | 2019-2020 | 100th Legislature | Introduced


Bill Title: Insurance; third party administrators; pharmacy benefit managers; regulate. Amends sec. 2 of 1984 PA 218 (MCL 550.902) by adding secs. 25, 26 & 27.

Spectrum: Partisan Bill (Republican 1-0)

Status: (Introduced - Dead) 2019-02-07 - Bill Electronically Reproduced 02/06/2019 [HB4155 Detail]

Download: Michigan-2019-HB4155-Introduced.html

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

HOUSE BILL No. 4155

 

 

February 6, 2019, Introduced by Rep. Vaupel and referred to the Committee on Government Operations.

 

     A bill to amend 1984 PA 218, entitled

 

"Third party administrator act,"

 

by amending section 2 (MCL 550.902) and by adding sections 25, 26,

 

and 27.

 

THE PEOPLE OF THE STATE OF MICHIGAN ENACT:

 

     Sec. 2. As used in this act:

 

     (a) "Administrative services manager" or "manager" means an

 

individual responsible for conducting the daily operations of a

 

third party administrator.

 

     (b) "Benefit plan" or "plan" means a medical, surgical,

 

dental, vision, or health care benefit plan and may include

 

coverage under a policy or certificate issued by a carrier.

 

     (c) "Board" means the TPA advisory board created under section

 

19.

 


     (d) "Carrier" means any of the following:

 

     (i) An an insurer, which is including a health maintenance

 

organization, regulated pursuant to under the insurance code of

 

1956, Act No. 218 of the Public Acts of 1956, being sections 1956

 

PA 218, MCL 500.100 to 500.8302, of the Michigan Compiled Laws.

 

     (ii) A medical care corporation regulated pursuant to Act No.

 

108 of the Public Acts of 1939, being sections 550.301 to 550.316

 

of the Michigan Compiled Laws.

 

     (iii) A hospital service corporation regulated pursuant to Act

 

No. 109 of the Public Acts of 1939, being sections 550.501 to

 

550.517 of the Michigan Compiled Laws.

 

     (iv) A health care corporation regulated pursuant to the

 

nonprofit health care corporation reform act, Act No. 350 of the

 

Public Acts of 1980, being sections 550.1101 to 550.1704 of the

 

Michigan Compiled Laws.

 

     (v) A health maintenance organization regulated under part 210

 

of the public health code, Act No. 368 of the Public Acts of 1978,

 

being sections 333.21001 to 333.21099 of the Michigan Compiled

 

Laws.

 

     (vi) A or a dental care corporation regulated pursuant to Act

 

No. 125 of the Public Acts of 1963, being sections under 1963 PA

 

125, MCL 550.351 to 550.373. of the Michigan Compiled Laws.

 

     (e) "Commissioner" means the commissioner of insurance of this

 

state.director.

 

     (f) "Department" means the department of insurance and

 

financial services.

 

     (g) "Director" means the director of the department.


     (h) (f) "ERISA" means the employee retirement income security

 

act of 1974, as amended, Public Law 93-406. , 88 Stat. 829.

 

     (i) "Manufacturer" means that term as defined in section 17706

 

of the public health code, 1978 PA 368, MCL 333.17706.

 

     (j) (g) "Person" means an individual, sole proprietorship,

 

partnership, corporation, association, or any other legal entity.

 

     (k) (h) "Personal data" means any record or information

 

pertaining to the diagnosis, treatment, or health of an individual

 

covered by a plan.

 

     (l) "Pharmacy" means that term as defined in section 17707 of

 

the public health code, 1978 PA 368, MCL 333.17707.

 

     (m) "Pharmacy benefit manager" means a person that contracts

 

with a pharmacy on behalf of an employer, multiple employer welfare

 

arrangement, public employee benefit plan, state agency, insurer,

 

managed care organization, or other third-party payer to provide

 

pharmacy health benefit services or administration.

 

     (n) (i) "Processes claims" means the administrative services

 

performed in connection with a claim for benefits under a plan.

 

     (o) (j) "Service contract" means the written agreement for the

 

provision of administrative services between the TPA and a plan, a

 

sponsor of a plan, or a carrier.

 

     (p) (k) "Third party administrator" or "TPA" means a person

 

who that processes claims pursuant to a service contract and who

 

that may also provide 1 or more other administrative services

 

pursuant to a service contract, other than under a worker's

 

compensation self-insurance program pursuant to section 611 of the

 

worker's disability compensation act of 1969, Act No. 317 of the


Public Acts of 1969, being section 1969 PA 317, MCL 418.611. of the

 

Michigan Compiled Laws. Third party administrator includes a

 

pharmacy benefit manager. Third party administrator does not

 

include a carrier or employer sponsoring a plan.

 

     Sec. 25. A person shall not establish or operate as a pharmacy

 

benefit manager unless the person registers with the director. A

 

person that violates this section is subject to a civil fine of not

 

more than $7,500.00.

 

     Sec. 26. (1) By May 1 of each year, a pharmacy benefit manager

 

shall provide the department with a report containing the following

 

information from the prior calendar year:

 

     (a) For each of the pharmacy benefit manager's contractual or

 

other relationships with an insurer, the aggregate amount of all

 

rebates that the pharmacy benefit manager received from

 

pharmaceutical manufacturers other than any of the following

 

rebates:

 

     (i) A pharmaceutical rebate provided under the Medicaid rebate

 

program under 42 USC 1396r-8.

 

     (ii) A pharmaceutical rebate provided under the Medicare drug

 

discount program under the social security act under title XVIII of

 

the social security act, 42 USC 1395 to 1395jjj, and the patient

 

protection and affordable care act, Public Law 111-148, as amended

 

by the health care and education reconciliation act of 2010, Public

 

Law 111-152.

 

     (iii) A pharmaceutical rebate provided under the 340b drug

 

pricing program under 42 USC 256b.

 

     (iv) A pharmaceutical rebate provided under the federal


prescription drug program as paid by the Department of Defense and

 

the Department of Veterans Affairs.

 

     (b) For each of the pharmacy benefit manager's contractual or

 

other relationships with an insurer, the aggregate rebates that the

 

pharmacy benefit manager received from pharmaceutical manufacturers

 

and did not pass through to the insurer.

 

     (c) For each of the pharmacy benefit manager's contractual or

 

other relationships with an insurer, the highest aggregate retained

 

rebate percentage, lowest aggregate retained rebate percentage, and

 

the mean aggregate retained rebate percentage.

 

     (2) The department shall publish in a timely manner the

 

information that it receives under subsection (1) on a publicly

 

available website. However, the information must be made available

 

in a form that does not disclose the identity of a specific insurer

 

or health plan, the prices charged for specific drugs or classes of

 

drugs, or the amount of any rebates provided for specific drugs or

 

classes of drugs. In developing the information to be published in

 

this section, the department shall consult with the 5 largest

 

carriers in this state, to be determined by the number of

 

enrollees, to ensure their identity is not able to be inferred

 

unknowingly on public disclosure.

 

     (3) The pharmacy benefit manager and the department shall not

 

publish or disclose any information that would reveal the identity

 

of a specific insurer or health plan, a price charged for a

 

specific drug or class of drugs, or the amount of any rebates

 

provided for a specific drug or class of drugs. The information

 

described in this subsection must be protected from disclosure as


confidential and proprietary information, and is exempt from

 

disclosure as a public record under section 13 of the freedom of

 

information act, 1976 PA 442, MCL 15.243.

 

     (4) As used in this section:

 

     (a) "Aggregated retained rebate percentage" means the

 

following percentage, calculated for each prescription drug for

 

which a pharmacy benefit manager receives rebates under a health

 

plan, and expressed without disclosing any identifying information

 

regarding the health plan, prescription drug, or therapeutic class:

 

     (i) Calculate the aggregate rebates that the pharmacy benefit

 

manager received during the prior calendar year from a

 

pharmaceutical manufacturer related to utilization of the

 

manufacturer's prescription drug by health plan insureds and did

 

not pass through to the health plan or insurer.

 

     (ii) Divide the result of the calculation under subparagraph

 

(i) by the aggregate rebates that the pharmacy benefit manager

 

received during the prior calendar year from a pharmaceutical

 

manufacturer related to utilization of the manufacturer's

 

prescription drug by health plan insureds.

 

     (b) "Rebates" means all rebates, discounts, education or

 

promotional funds, and other price concessions, based on

 

utilization of a prescription drug and paid by the manufacturer or

 

other party, other than an insured, directly or indirectly, to the

 

pharmacy benefit manager after the claim has been adjudicated at

 

the pharmacy. Rebates include a reasonable estimate of any volume-

 

based or other discounts.

 

     Sec. 27. A contract between a pharmacy benefit manager and a


pharmacy or between a pharmacy benefit manager and any other

 

entity, including, but not limited to, a manufacturer, must not

 

prohibit or penalize a pharmacy or any other entity for doing any

 

of the following:

 

     (a) Disclosing to a customer information regarding either of

 

the following:

 

     (i) The cost sharing amounts that the customer must pay for a

 

particular prescription drug under his or her health plan's

 

prescription drug benefit or, without requesting any health plan

 

reimbursement, outside his or her health plan's prescription drug

 

benefit, or both.

 

     (ii) The existence and clinical efficacy of a therapeutically

 

equivalent drug that would be less expensive to the customer under

 

his or her health plan's prescription drug benefit or outside his

 

or her health plan's prescription drug benefit, or both, without

 

requesting any health plan reimbursement, than the drug that was

 

originally prescribed.

 

     (b) Selling to a customer, instead of a particular prescribed

 

drug, a therapeutically equivalent drug that would be less

 

expensive to the customer under his or her health plan's

 

prescription drug benefit or outside his or her health plan's

 

prescription drug benefit, without requesting any health plan

 

reimbursement, than the drug that was originally prescribed.

feedback